Pay in 4 interest-free payments of $5.12 Learn more
Ships within 48 hours · Estimated delivery Oct 24 - Oct 29
Provider oversight Every prescription decision is made by a licensed medical provider after a clinical evaluation
(Source: WeightSherpa, March 2026) ObesityWeek 2025 Real-World Tirzepatide Data Real-world data presented at ObesityWeek 2025 showed over 90% of PCOS patients lost at least 10% of body weight within 10 months on tirzepatide, with a mean weight loss of 18.81% comparable to tirzepatides general SURMOUNT-1 trial results (22.5% at the highest dose)
Injecting it intramuscularly or subcutaneously allows for significantly greater absorption and availability in the bloodstream
Supported by progress in targeted delivery systems, these multifaceted mechanisms underscore its significant potential for clinical application (80)
